...
首页> 外文期刊>The Turkish journal of pediatrics >Molecular diagnosis of Fanconi anemia with next-generation sequencing in a case with subtle signs and a negative chromosomal breakage test
【24h】

Molecular diagnosis of Fanconi anemia with next-generation sequencing in a case with subtle signs and a negative chromosomal breakage test

机译:细微征兆和染色体断裂试验阴性的病例,采用下一代测序技术对范可尼贫血进行分子诊断

获取原文
获取原文并翻译 | 示例
           

摘要

Fanconi anemia (FA) is an inherited disorder characterized by malformations, marrow failure, and predisposition to cancer. Birth defects and laboratory features are characteristic and helpful in diagnosis, when present. Chromosome fragility is pathognomonic in the diagnosis. However, in some cases, there are no obvious physical anomalies or suggestive hematologic abnormalities, and inconclusive diagnostic tests have also been described. In such cases, a molecular diagnosis is required. This approach presents some advantages, especially in populations with a high incidence of FA and of consanguinity. Herein, we present a case with mild phenotypic features, inconclusive hematological findings and a negative breakage test. The diagnosis of FA was confirmed with next-generation sequencing. To our knowledge, this is the first publication of a FA patient being molecularly diagnosed utilizing this method since its introduction. Given its technical and financial features, we suggest that next-generation sequencing might be an alternative first-line diagnostic test for selected cases from particular populations.
机译:范可尼贫血(FA)是一种遗传性疾病,其特征在于畸形,骨髓衰竭和易患癌症。如果存在,出生缺陷和实验室特征是特征性的,并且有助于诊断。染色体脆性在诊断中是病态的。但是,在某些情况下,没有明显的身体异常或暗示的血液学异常,并且还描述了不确定的诊断测试。在这种情况下,需要进行分子诊断。这种方法具有一些优势,尤其是在FA和血缘病发病率较高的人群中。在此,我们介绍了一个具有轻度表型特征,无定论的血液学发现和阴性破损试验的病例。下一代测序证实了FA的诊断。据我们所知,这是自该方法问世以来首次利用该方法进行分子诊断的FA患者。鉴于其技术和财务特征,我们建议对于特定人群中的特定病例,下一代测序可能是替代的一线诊断测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号